Patrick J. McEnany - 18 Nov 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
18 Nov 2022
Net transactions value
-$6,647,500
Form type
4
Filing time
22 Nov 2022, 16:00:16 UTC
Previous filing
15 Sep 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $784,000 +350,000 +9% $2.24* 4,252,606 18 Nov 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $5,467,700 -350,000 -8.2% $15.62 3,902,606 18 Nov 2022 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $336,000 +150,000 +3.8% $2.24* 4,052,606 21 Nov 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $2,299,800 -150,000 -3.7% $15.33 3,902,606 21 Nov 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -350,000 -10% $0.000000 3,015,834 18 Nov 2022 Common Stock 350,000 $2.24 Direct F4
transaction CPRX Options to purchase common stock Options Exercise $0 -150,000 -5% $0.000000 2,865,834 21 Nov 2022 Common Stock 150,000 $2.24 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.50 to $16.06 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.19 to $15.55 per share.
F4 Options vested in three equal tranches on December 19, 2019, 2020 and 2021.